Cargando…
A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects
A novel neuroendocrine peptide, pituitary adenylate cyclase activating peptide (PACAP), was found to have an important role in carbohydrate or lipid metabolism and was susceptible to dipeptidyl peptidase IV degradation. It can not only mediate glucose-dependent insulin secretion and lower blood gluc...
Autores principales: | Zhao, Shao-Jun, Wang, De-Hua, Li, Yan-Wei, Han, Lei, Xiao, Xing, Ma, Min, Wan, David Chi-Cheong, Hong, An, Ma, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367579/ https://www.ncbi.nlm.nih.gov/pubmed/28356733 http://dx.doi.org/10.2147/IJN.S130566 |
Ejemplares similares
-
Role of VPAC1 and VPAC2 receptors in the etiology of pregnancy rhinitis: an experimental study in rats
por: Ulkumen, Burak, et al.
Publicado: (2020) -
Understanding VPAC receptor family peptide binding and selectivity
por: Piper, Sarah J., et al.
Publicado: (2022) -
Thiolated Chitosan Conjugated Liposomes for Oral Delivery of Selenium Nanoparticles
por: Selmani, Atiđa, et al.
Publicado: (2022) -
Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes
por: Hou, Xintong, et al.
Publicado: (2022) -
Seasonal changes in the expression of PACAP, VPAC1, VPAC2, PAC1 and testicular activity in the testis of the muskrat (Ondatra zibethicus)
por: Tang, Zeqi, et al.
Publicado: (2022)